Use of a spontaneous adverse drug events database for identification of unanticipated drug benefits
Allen D. Brinker, Julie G. Beitz · Clinical Pharmacology & Therapeutics · 2002
We describe an examination of a spontaneous adverse events database in an effort to identify agents with possible hitherto unknown antiangiogenic properties. The surrogate end point was abnormal wound healing. This analysis represents use of this database for identification of a possibly useful in vivo side effect. Through thoughtful choice of end points, we believe spontaneous adverse events databases have the capacity for hypothesis generation in a search for unanticipated beneficial drug properties.